Total Results: 15888
A new poll reveals that most Americans don’t think the plan will lower health care costs.
A growing number of patients fail to fill prescriptions because the cost of cancer drugs is too high.
A selection of opinions on health care from across the country.
With Republicans in control of Congress and the White House, HSAs — a longtime favorite of conservatives — are likely to get a boost.
Modern Healthcare reports on the problem of violence at work and the debate on how to protect nurses, doctors and other medical staff.
The House Committee on Education and the Workforce approved legislation that would allow employers to ding workers up to 30 percent of the cost of their health insurance if they refuse to participate in genetic testing as part of a company’s wellness program.
The proposal will hit older, low-income rural people the hardest.
Sen. Patty Murray of Washington, the top Democrat on the Health, Labor, Education and Pensions Committee, says the legislation is a “slap in the face” to women.
The Associated Press looks at the aspects of the Affordable Care Act that may be affected by the repeal and replace plan.
Both Health and Human Services Secretary Tom Price and Vice President Mike Pence spoke out in defense of the American Health Care Act over the weekend.
President Donald Trump holds off from wading into the public debate quite yet.
In its investigation of why health care costs are so high, ProPublica reports on the perfectly good stuff hospitals and medical personnel throw away. In other marketplace news, Stat writes about how changes to the work visa program could impact the medical industry while KHN looks into insurers steering beneficiaries to “preferred” pharmacies.
Blue Shield of California is hoping to steer consumers to “preferred” pharmacies where drugs are cheaper and copays lower.
In other news on pharmaceutical costs, Sen. Chuck Grassley (R-Iowa) questions Kaleo about the $4,500 price tag of its EpiPen alternative and some payers are denying coverage of pricey hepatitis C treatments, despite more discounts.
The Washington Post fact checks Sen. Chuck Schumer’s claim regarding the number of women who get mammograms through the women’s reproductive health group, while Planned Parenthood officials push back on Republicans’ efforts to defund the organization. In other news from Capitol Hill, Sen. Susan Collins (R-Maine) introduces a bill aimed at surprise bills after a colonoscopy.
House GOP leaders chose to move ahead with consideration of the American Health Care Act in two key committees — Ways and Means and Energy and Commerce — without an official, independent estimate by the Congressional Budget Office of the measure’s cost and coverage. This move has raised the ire of many of the bill’s opponents, including House conservatives, who want to know more about its cost implications.
Two Democratic congressmen met with President Trump to seek his support for a bill to expand the government’s ability to negotiate drug prices, but it’s not clear it would have much impact or will gain support.
Read recent commentaries about drug-cost issues.
News outlets report on stories related to pharmaceutical drug pricing.
Health care companies are still parsing the new legislation but some of the moves are bound to please — such as the elimination of some taxes — while others are cause for concern.